Bayer gets Breakthrough Therapy designation in China for lung cancer drug BAY 2927088 Ruchika Sharma15 Jun 2024 10:00 AM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has...
Bayer, Evotec ink pact to advance precision cardiology Ruchika Sharma2 May 2024 3:09 PM ISTBerlin: Bayer and the German-based life science company, Evotec, have announced that they have updated the focus of their strategic collaboration...
Bayer AG arm AskBio names Mansuo Shannon as Chief Scientific Officer Ruchika Sharma14 April 2024 1:00 PM ISTResearch Triangle Park: Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has...
Bayer, Google Cloud to accelerate development of AI-powered healthcare applications for radiologist Ruchika Sharma11 April 2024 9:00 AM ISTBerlin: Bayer and Google Cloud have announced a collaboration on the development of artificial intelligence (AI) solutions to support...
Dr Reddy's Labs, Bayer collaborate to market, distribute second brand of heart failure drug Vericiguat in India Ruchika Sharma6 April 2024 2:00 PM ISTHyderabad: Dr Reddy's Laboratories Ltd. and Bayer announced that both companies have entered into a partnership to market and distribute a...
Bayer, Thermo Fisher Scientific join hands to increase patient access to precision cancer medicines Ruchika Sharma25 March 2024 12:30 PM ISTBerlin: Bayer AG and Thermo Fisher Scientific Inc. have announced a collaboration to develop next-generation sequencing (NGS)-based companion...
Bayer shareholder Harris backs CEO focus on internal restructuring Ruchika Sharma8 March 2024 3:01 PM ISTIn a written response to a Reuters request for comment, Herro said the CEO was rightly focusing on efforts to "turn three very good businesses into...
Bayer to hold off on plans to break apart group for up to 3 years Ruchika Sharma6 March 2024 1:30 PM ISTFrankfurt: Bayer will hold off on plans to break apart the group for up to three years so that the new CEO can focus on problems including debt...
Bayer buys exclusive marketing rights for cardiology drug Acoramidis in Europe Ruchika Sharma4 March 2024 3:30 PM ISTUnder the terms of the agreement, BridgeBio and the affiliates will receive up to USD 310 million in upfront and near-term milestone payments and are...
Bayer gets USFDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations Ruchika Sharma29 Feb 2024 1:30 PM ISTBAY 2927088 was derived from Bayer's long-standing strategic research alliance with the Broad Institute of MIT and Harvard in Cambridge, MA, USA.
Bayer begins Phase II study with anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis Ruchika Sharma23 Feb 2024 2:30 PM ISTBerlin: Bayer has announced the start of a Phase II clinical trial (SIRIUS study) with BAY3018250, an investigational first-in-class anti-alpha2...
German drugmaker Bayer cuts dividends to legal minimum to reduce debt Ruchika Sharma20 Feb 2024 2:50 PM ISTFrankfurt: German drugmaker Bayer said that it was amending its dividend policy to pay the legal minimum for a period of three years to reduce...
